back to Australia directory
australia clinical guidance

Hypertension

A detailed Australian summary of hypertension, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm persistently raised office blood pressure with ambulatory or structured home measurements when feasible, using validated equipment and correct cuff technique. Assess target-organ injury, kidney disease, diabetes and absolute cardiovascular risk before setting treatment intensity and follow-up priorities. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

The Bottom Line

  • Confirm persistently raised office blood pressure with ambulatory or structured home measurements when feasible, using validated equipment and correct cuff technique.
  • Assess target-organ injury, kidney disease, diabetes and absolute cardiovascular risk before setting treatment intensity and follow-up priorities.
  • Check both arms initially and use the higher arm for subsequent measurements when a persistent inter-arm difference is confirmed.
  • Lifestyle care should address sodium intake, weight, physical activity, alcohol, smoking and sleep apnoea without delaying medicine when risk is high.
sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

Practical clinical workflow

1

Topic-specific assessment action

Confirm persistently raised office blood pressure with ambulatory or structured home measurements when feasible, using validated equipment and correct cuff technique.
2

Topic-specific diagnostic action

Lifestyle care should address sodium intake, weight, physical activity, alcohol, smoking and sleep apnoea without delaying medicine when risk is high.
3

Topic-specific management action

Apparent resistant hypertension requires confirmation of adherence and out-of-office pressure, removal of pressor medicines and investigation for secondary causes.
4

Topic-specific follow-through

Assess orthostatic blood pressure in older people and those with dizziness, diabetes or autonomic symptoms before intensifying therapy.
sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

Safety boundaries and escalation

  • Severe hypertension with retinal change, neurological symptoms, chest pain, pulmonary oedema or acute kidney injury requires urgent hospital assessment.
  • After each renin–angiotensin blocker or diuretic change, arrange kidney-function and electrolyte monitoring matched to baseline risk.
sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Heart Foundation hypertensionAustralian CVD risk guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. National Heart Foundation of AustraliaGuideline for the diagnosis and management of hypertension in adults — 2016ISBN 978-1-74345-110-6 · 2016 guideline; current Heart Foundation document checked 2026-08-20 · accessed 2026-08-20
    view source
  2. Australian Government Department of Health and Aged CareAustralian Guideline for assessing and managing cardiovascular disease riskISBN 978-1-76007-570-5 · 2023 guideline · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.